“Devatis, Inc.
provides value added and cost effective products of the highest quality to deliver therapeutic solutions to healthcare
professionals and patients with medical needs.”
Philipp Haas,Chairman of the Board of Directors & CEO
DEVA Holding has more than 650 products in 14 therapeutic areas including oncology, ophthalmology and respiratory system products among others. DEVA Holding has been creating difference by releasing new products into market every single year.
We exist to offer innovative and diversified range of products with a high quality experience enabling healthy life opportunity to be available to everyone on a global scale.
VISION:
To become the first choice by creating robust pharmaceutical brands in the areas we compete in.
